Lara Kujtan, MD, sheds light on how to navigate the complex paradigm of oncogene-driven non–small cell lung cancer and stressed the importance of patient preferences when deciding on optimal treatment approaches.
Original Article: Navigating the Complex Paradigm of Oncogene-Driven NSCLC